S32

States its goal as improving the human condition by accelerating the discovery, development and distribution of important technologies and life-saving medicines - investing across software, security, computation, space, climate, machine learning, therapeutics, diagnostics and genomics.

$740M (Fund 4, 2021) AUM 68/100 Power Score™ 2017 Founded Palo Alto, CA
Healthcare Biotech Deep Tech
View Live Interactive Profile → Visit S32's Website ↗

Signature Exit

Key Partners & Leadership

Founder
CEO & General Partner
General Partner
General Partner
General Partner

Firm Timeline

2017
Founded by Bill Maris; debut fund closed at $150M against a $100M target.
2019
Second fund closed at $199.4M.
2021
Fund 4 closed at $740M, taking total firm assets past $1.8B.